Coca-Cola HBC to buy Africa's biggest Coke bottler

Coca-Cola HBC (CCH) has agreed to acquire a 75% stake in Coca-Cola Beverages Africa (CCBA) for $2.6 billion, a strategic move that will establish it as the world's second-largest drinks bottler and significantly expand its footprint across 14 African markets. The acquisition, expected to be low single-digit EPS accretive from 2027, will be financed via bridge funding and new share issuance, with a secondary listing planned for Johannesburg. Separately, CCH reported Q3 organic sales growth of 5%, below consensus, but reaffirmed its full-year organic revenue and EBIT growth guidance at the top end of their respective ranges.

Analysis

Coca-Cola HBC (CCH) has announced a significant strategic acquisition, agreeing to purchase a 75% stake in Coca-Cola Beverages Africa (CCBA) for $2.6 billion. This transaction is poised to elevate CCH to the world's second-largest drinks bottler, substantially expanding its operational footprint across 14 African countries, complementing its existing presence in Nigeria and Egypt. The move capitalizes on Africa's "sizable and growing consumer base" and "significant opportunities to increase per capita consumption," as highlighted by CEO Zoran Bogdanovic.

The acquisition is projected to be low single-digit EPS accretive from the first full year post-completion, targeted for the end of 2026. Funding will be a combination of bridge financing and new share issuance, with the latter representing 5.47% of CCH's outstanding share capital, alongside a planned secondary listing on the Johannesburg Stock Exchange. A separate option agreement allows CCH to acquire the remaining 25% of CCBA from The Coca-Cola Company (KO) within six years.

Despite the strategic expansion, CCH reported Q3 organic sales growth of 5%, falling short of consensus expectations of 6.3%. This underperformance was attributed to less favorable weather, a tougher consumer backdrop, and moderating inflationary pricing impacting both volume and price/mix. However, the company reaffirmed its full-year organic revenue growth guidance at the top end of the 6-8% range and organic EBIT growth at the top end of the 7-11% range, supported by 8.1% organic revenue growth over the first nine months.

Key Decisions for Investors

• Investors should assess the long-term growth potential of CCH, considering the strategic acquisition of CCBA significantly enhances its exposure to high-growth African markets and its global market position.
• Monitor the integration process and the realization of expected low single-digit EPS accretion from the CCBA acquisition, balancing this against the 5.47% share dilution from the funding structure.
• While Q3 organic sales missed expectations, the reaffirmed full-year guidance suggests underlying resilience; focus on the company's ability to maintain top-end guidance amidst challenging market conditions and the strategic benefits of the acquisition.